Testing how new Crohn’s imaging and scopes predict outcomes
Part of Digestive system clinical trials.
This study follows children newly diagnosed with Crohn’s disease to see how results from scans and endoscopy (camera scope) relate to outcomes over the first year. It may help doctors choose better early treatment plans and monitor children more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 6 and under 18 years old when you enroll
- Have a suspected Crohn’s diagnosis at the start (and stool tests that don’t explain the diarrhea)
- Be able to stay in the study for follow-up visits for about 6 months at first and at least 52 weeks after starting anti-TNF therapy
- If there’s a need for Crohn’s confirmation, avoid cases where Crohn’s is found only after bowel surgery right away
- Be able to have an MRI scan (MRE); claustrophobia or other barriers may exclude you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at outcomes after children with Crohn’s disease have part of the bowel removed (ileo-cecal resection). It may help doctors improve post-surgery care, especially for preventing flare-ups in the months after surgery.
This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
This trial studies “autophagy,” a normal body process, to better understand and possibly improve care for children with Crohn’s disease. Children will need a scope exam and may get assigned to a Crohn’s group or a non-Crohn’s group for comparison.
This study is for children and teens with inflammatory bowel disease (Crohn's, colitis, or indeterminate) whose previous anti-TNF medicine stopped working. It compares several newer treatments to see which works best.
This study looks at people with Crohn's disease that is hard to treat. It aims to understand the disease better and see how well current treatments work.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.